HRTX Heron Therapeutics, Inc. - Common Stock
$0,31
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 10, 2026
Rango 52S
$0–$2
0% of range
Calificación del Analista
BUY
8 analysts
Precio Objetivo
$2
+553% upside
P/E (TTM)
-2.6
ROE
312.5%
Margen de Beneficio Neto
-13.0%
HRTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.31
Capitalización Bursátil
$58M
P/E (TTM)
-2.6
BPA (TTM)
$-0.12
Ingresos (TTM)
$155M
Rendimiento div.
—
ROE
312.5%
Deuda/Capital
—
Rango 52S
$0 – $2
HRTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$155M
2016-12-31
→
2025-12-31
BPA
$-0.12
2021-12-31
→
2025-12-31
Flujo de caja libre
$-28M
2016-12-31
→
2025-12-31
Márgenes
-13.0%
2023-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
HRTX
Mediana de Pares
P/E (TTM)
-2.6
—
P/S (TTM) (P/V (TTM))
0.4
165.8
P/B (P/C)
4.0
1.6
Price / FCF (Precio / FCF)
-2.1
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
HRTX
Mediana de Pares
Gross Margin (Margen Bruto)
73.3%
71.1%
Operating Margin (Margen Operativo)
-1.6%
—
Net Profit Margin (Margen de Beneficio Neto)
-13.0%
-2229.6%
ROA
-8.3%
-64.3%
ROE
312.5%
-102.1%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
HRTX
Mediana de Pares
Current Ratio (Ratio corriente)
2.5
4.8
Quick Ratio (Ratio Rápido)
1.2
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
HRTX
Mediana de Pares
Revenue YoY (Ingresos interanuales)
7.4%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
12.9%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
11.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
HRTX
Mediana de Pares
HRTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
8 analistas
- Compra fuerte 2 25,0%
- Compra 4 50,0%
- Mantener 2 25,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
1 analistas · 2026-08-13
Mín
$2.00
Máx
$2.00
Objetivo mediano
$2.00
+553,2%
Objetivo medio
$2.00
+553,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.01%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.03 | $0.01 | -0.04% |
| 31 de marzo de 2026 | $-0.04 | $-0.02 | -0.02% |
| 31 de diciembre de 2025 | $-0.02 | $-0.02 | 0.00% |
| 30 de septiembre de 2025 | $-0.04 | $-0.02 | -0.02% |
| 30 de junio de 2025 | $-0.02 | $-0.01 | -0.01% |
| 31 de marzo de 2025 | $0.01 | $-0.01 | 0.02% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Cost of Revenue | $41M | $39M | $65M | $55M | $46M | $36M | $62M | $28M | $5M | $35.0K | |
| Gross Profit | $114M | $106M | $62M | $53M | · | · | · | · | · | · | |
| R&D Expense | $12M | $17M | $39M | $83M | $131M | $175M | $167M | $140M | $139M | $103M | |
| SG&A Expense | $55M | $53M | $66M | $62M | $40M | $42M | $38M | $29M | $26M | $21M | |
| Operating Expenses | $116M | $117M | $173M | $227M | $304M | $317M | $357M | $261M | $225M | $172M | |
| Operating Income | $-3M | $-12M | $-111M | $-175M | $-218M | $-228M | $-211M | $-184M | $-195M | $-171M | |
| Interest Expense | · | · | $4M | $2M | $2M | $2M | $1M | $3M | $4M | $3M | |
| Interest Income | $2M | $4M | $3M | $2M | $433.0K | $4M | $7M | $6M | $1M | $445.0K | |
| Other Non-op | $1M | $430.0K | $560.0K | $-7M | $-878.0K | $-847.0K | $158.0K | $2M | $-38.0K | $-9.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| EPS (Basic) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| Shares (Basic) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| Shares (Diluted) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| EBITDA | $-224.0K | $-9M | $-108M | $-172M | $-215M | $-225M | $-209M | $-182M | $-193M | $-171M |
Balance general 23
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $26M | $29M | $15M | $91M | $105M | $72M | $32M | $145M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | $301M | $28M | $38M | |
| Receivables | $90M | $79M | $60M | $52M | $35M | $42M | $40M | $65M | $42M | $2M | |
| Inventory | $93M | $53M | $42M | $55M | $48M | $42M | $25M | $39M | $10M | $5M | |
| Prepaid Expense | $9M | $18M | $6M | $14M | $13M | $22M | $23M | $11M | $4M | $4M | |
| Current Assets | $238M | $209M | $189M | $205M | $254M | $314M | $479M | $447M | $228M | $62M | |
| PP&E (Net) | $12M | $15M | $20M | $22M | $24M | $23M | $20M | $15M | $6M | $5M | |
| PP&E (Gross) | $25M | $33M | $37M | $36M | $37M | $34M | $28M | $23M | $14M | $12M | |
| Accum. Depreciation | $13M | $18M | $17M | $14M | $13M | $11M | $8M | $8M | $8M | $7M | |
| Other Non-current Assets | $5M | $6M | $8M | $16M | $18M | $346.0K | $346.0K | $254.0K | $263.0K | $263.0K | |
| Total Assets | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Accounts Payable | $9M | $12M | $3M | $3M | $4M | $525.0K | $3M | $17M | $19M | $7M | |
| Current Liabilities | $96M | $91M | $80M | $82M | $71M | $103M | $97M | $92M | $103M | $39M | |
| Capital Leases | $0 | · | $3M | $5M | $8M | $15M | $12M | · | · | · | |
| Other Non-current Liabilities | $5M | $615.0K | $241.0K | $241.0K | · | · | · | · | · | · | |
| Total Liabilities | $242M | $267M | $256M | $237M | $228M | $117M | $109M | $92M | $103M | $89M | |
| Common Stock | $2M | $2M | $2M | $1M | $1M | $913.0K | $903.0K | $782.0K | $646.0K | $394.0K | |
| Paid-in Capital | $1.95B | $1.88B | $1.87B | $1.81B | $1.69B | $1.63B | $1.57B | $1.33B | $914M | $564M | |
| Retained Earnings | $-1.94B | $-1.92B | $-1.91B | $-1.80B | $-1.61B | $-1.39B | $-1.17B | $-961M | $-783M | $-586M | |
| AOCI | $4.0K | $13.0K | $13.0K | $-19.0K | $-6.0K | $257.0K | $85.0K | $-87.0K | $-10.0K | $-17.0K | |
| Stockholders' Equity | $14M | $-34M | $-34M | $14M | $78M | $236M | $404M | $370M | $131M | $-21M | |
| Liabilities + Equity | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Shares Outstanding | 188,314,430 | 152,127,878 | 150,285,044 | 119,154,538 | 102,005,000 | 91,310,000 | 90,304,000 | 78,174,000 | 64,609,000 | 39,355 |
Flujo de Efectivo 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $10M | $13M | $33M | $43M | $47M | $50M | $51M | $33M | $31M | $26M | |
| Restructuring | · | · | · | · | · | $6M | · | · | · | · | |
| Other Non-cash | $-20M | $-24M | $16M | $-11M | $-33M | $-11M | $27M | $-48M | $-5M | · | |
| Operating Cash Flow | $-28M | $-23M | $-59M | $-147M | $-203M | $-185M | $-125M | $-192M | $-170M | $-134M | |
| CapEx | $317.0K | $2M | $2M | $2M | $3M | $7M | $7M | $9M | $3M | $3M | |
| Investing Cash Flow | $16M | $19M | $18M | $-3M | $33M | $209M | $-22M | $-279M | $8M | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $-25M | $-25M | · | |
| Stock Issued | $18M | · | $30M | $75M | · | · | $162M | $363M | $306M | · | |
| Net Stock Activity | $18M | · | $30M | $75M | · | · | $162M | · | · | · | |
| Financing Cash Flow | $14M | $940.0K | $54M | $75M | $156M | $9M | $186M | $358M | $294M | $57M | |
| Net Change in Cash | $3M | $-3M | $13M | $-75M | $-15M | $33M | $40M | $-113M | $131M | $-62M | |
| Free Cash Flow | $-28M | $-24M | $-60M | $-149M | $-206M | $-192M | $-132M | $-201M | $-173M | $-137M |
Rentabilidad 6
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.2% | 48.8% | · | · | · | · | · | · | · | |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% | |
| Net Margin | -13.0% | -9.4% | -87.0% | -169.0% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% | |
| EBITDA Margin | -0.14% | -6.3% | -84.8% | -159.5% | -248.8% | -254.2% | -142.9% | -235.5% | -627.4% | -13363.2% | |
| ROA | -8.3% | -6.0% | -46.7% | -65.4% | -67.0% | -52.5% | -42.0% | -51.3% | -130.9% | -168.7% | |
| ROE | 312.5% | 36.9% | 358.0% | -1010.6% | -224.7% | -88.5% | -59.4% | -46.0% | -359.4% | -357.5% |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 | 3.1 | 5.0 | 4.9 | 2.2 | 1.6 | |
| Quick Ratio | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 | 1.4 | 1.2 | 4.3 | 2.1 | 1.4 | |
| Interest Coverage | · | · | -28.6 | -70.6 | -90.4 | -120.0 | -143.1 | -68.8 | -49.4 | -64.2 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.0 | |
| Inventory Turnover | 0.6 | 0.8 | 1.3 | 1.1 | 1.0 | 1.1 | 1.9 | 1.1 | 0.6 | 0.0 | |
| Receivables Turnover | 1.8 | 2.1 | 2.3 | 2.5 | 2.2 | 2.2 | 2.8 | 1.5 | 1.4 | 1.3 |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.4% | 13.6% | 18.0% | 24.7% | -2.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 18.7% | 12.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Net Income TTM | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| Market Cap | $245M | $233M | $255M | $298M | $931M | $1.93B | $2.12B | $2.03B | $1M | $516M | |
| P/E | -10.8 | -17.0 | -2.1 | -1.5 | -4.1 | · | · | · | · | · | |
| P/S | 1.6 | 1.6 | 2.0 | 2.8 | 10.8 | 21.8 | 14.5 | 26.2 | 0.0 | 403.1 | |
| P/B | 17.1 | -6.9 | -7.5 | 21.9 | 12.0 | 8.2 | 5.3 | 5.5 | 0.0 | -24.3 | |
| P / Tangible Book | 17.1 | · | · | 21.9 | 12.0 | 8.2 | · | · | · | · | |
| P / Cash Flow | -8.9 | -10.3 | -4.3 | -2.0 | -4.6 | -10.5 | -17.0 | -10.6 | -0.0 | -3.8 | |
| P / FCF | -8.8 | -9.6 | -4.2 | -2.0 | -4.5 | -10.1 | -16.1 | -10.1 | -0.0 | -3.8 | |
| Earnings Yield | -9.2% | -5.9% | -47.1% | -66.8% | -24.5% | · | · | · | · | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $35M | $41M | $38M | $37M | $39M | $41M | $33M | $36M | $35M | $34M | $31M | $32M | $30M | $30M | $27M | |
| Cost of Revenue | $12M | $11M | $11M | $12M | $10M | $8M | $10M | $9M | $11M | $8M | $10M | $18M | $20M | $17M | $13M | $15M | |
| Gross Profit | $26M | $24M | $29M | $26M | $27M | $30M | $31M | $23M | $26M | $26M | $24M | $13M | $12M | $13M | $17M | $12M | |
| R&D Expense | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $4M | $5M | $8M | $9M | $13M | $9M | $-14M | $26M | |
| SG&A Expense | $11M | $12M | $13M | $14M | $14M | $13M | $12M | $12M | $14M | $15M | $14M | $16M | $20M | $16M | $34M | $10M | |
| Operating Expenses | $28M | $29M | $29M | $30M | $29M | $27M | $26M | $28M | $32M | $31M | $35M | $38M | $54M | $46M | $10M | $54M | |
| Operating Income | $-2M | $-5M | $38.0K | $-4M | $-2M | $3M | $4M | $-4M | $-6M | $-5M | $-10M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| Other Non-op | $-3M | $-3M | $5M | $-2M | $-744.0K | $-519.0K | $2M | $-390.0K | $-3M | $2M | $0 | $-79.0K | $344.0K | $295.0K | $1M | $-26.0K | |
| Net Income | $-5M | $-8M | $-3M | $-17M | $-2M | $3M | $4M | $-5M | $-9M | $-3M | $-11M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| EPS (Basic) | $-0.03 | $-0.04 | $-0.02 | $-0.10 | $-0.02 | $0.02 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| EPS (Diluted) | $-0.03 | $-0.04 | $-0.01 | $-0.10 | $-0.02 | $0.01 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| Shares (Basic) | 190,335,000 | 189,646,000 | -311,151,000 | 170,348,000 | 154,020,000 | 153,490,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| Shares (Diluted) | 190,335,000 | 189,646,000 | -354,582,000 | 170,348,000 | 154,020,000 | 196,921,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| EBITDA | $-2M | $-4M | · | $-4M | $-2M | $4M | · | $-4M | $-6M | $-4M | · | $-25M | $-42M | $-32M | · | $-42M |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $26M | $29M | $43M | $17M | $19M | $26M | $26M | $18M | $20M | · | $35M | $13M | $27M | · | $50M | |
| Receivables | $90M | $84M | $90M | $81M | $80M | $79M | $79M | $67M | $74M | $65M | · | $64M | $77M | $51M | · | $42M | |
| Inventory | $91M | $93M | $93M | $70M | $73M | $57M | $53M | $46M | $43M | $42M | · | $42M | $45M | $52M | · | $52M | |
| Prepaid Expense | $7M | $8M | $9M | $23M | $17M | $26M | $18M | $11M | $7M | $7M | · | $11M | $11M | $15M | · | $8M | |
| Current Assets | $230M | $229M | $238M | $229M | $211M | $213M | $209M | $195M | $191M | $186M | · | $194M | $165M | $178M | · | $224M | |
| PP&E (Net) | $12M | $12M | $12M | $13M | $14M | $15M | $15M | $15M | $16M | $19M | · | $21M | $21M | $22M | · | $23M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $13M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $8M | · | $8M | $9M | $14M | · | $17M | |
| Total Assets | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Accounts Payable | $12M | $9M | $9M | $12M | $12M | $12M | $12M | $10M | $10M | $837.0K | · | $2M | $2M | $4M | · | $7M | |
| Current Liabilities | $92M | $91M | $96M | $90M | $259M | $89M | $91M | $86M | $80M | $75M | · | $80M | $87M | $78M | · | $94M | |
| Capital Leases | $6M | · | · | · | · | · | · | $522.0K | $1M | $2M | · | $4M | $4M | $5M | · | $6M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $747.0K | $682.0K | $615.0K | $241.0K | $241.0K | $241.0K | · | $241.0K | $241.0K | $241.0K | · | $241.0K | |
| Total Liabilities | $245M | $237M | $242M | $234M | $259M | $264M | $267M | $261M | $256M | $252M | · | $257M | $241M | $232M | · | $250M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.96B | $1.95B | $1.95B | $1.94B | $1.89B | $1.89B | $1.88B | $1.88B | $1.88B | $1.87B | · | $1.87B | $1.83B | $1.82B | · | $1.80B | |
| Retained Earnings | $-1.95B | $-1.95B | $-1.94B | $-1.94B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.91B | · | $-1.90B | $-1.87B | $-1.83B | · | $-1.78B | |
| AOCI | $-6.0K | $-6.0K | $4.0K | $0 | $-1.0K | $1.0K | $13.0K | $40.0K | $-8.0K | $-6.0K | · | $-1.0K | $-6.0K | $9.0K | · | $-57.0K | |
| Stockholders' Equity | $7M | $9M | $14M | $15M | $-27M | $-28M | $-34M | $-40M | $-38M | $-34M | $-34M | $-28M | $-39M | $-11M | $14M | $22M | |
| Liabilities + Equity | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Shares Outstanding | · | · | 188,314,430 | · | · | · | 152,127,878 | · | · | · | · | · | · | · | · | · |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $452.0K | $529.0K | $537.0K | $615.0K | $611.0K | $551.0K | $581.0K | $581.0K | $641.0K | $689.0K | $715.0K | $727.0K | $739.0K | $718.0K | $791.0K | $706.0K | |
| Stock-based Comp | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $5M | $3M | $4M | $7M | $14M | $8M | $11M | $11M | |
| Other Non-cash | · | $3M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-797.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-9M | $1M | $-11M | $-9M | $-12M | $3M | $-5M | $-10M | $2M | $-9M | $-27M | $-25M | $-38M | $-37M | |
| CapEx | $138.0K | $391.0K | $0 | $0 | $208.0K | $109.0K | $638.0K | $431.0K | · | · | $250.0K | $793.0K | $278.0K | $224.0K | $414.0K | $45.0K | |
| Investing Cash Flow | $-3M | $-939.0K | $-5M | $12M | $7M | $2M | $11M | $4M | $2M | $1M | $-9M | $-23M | $13M | $37M | $2M | $-36M | |
| Stock Issued | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $82.0K | $-51.0K | $219.0K | $13M | $781.0K | $64.0K | $423.0K | $14.0K | $492.0K | $11.0K | $199.0K | $54M | $319.0K | $-208.0K | $439.0K | $75M | |
| Net Change in Cash | $-5M | $-3M | $-14M | $27M | $-3M | $-7M | $61.0K | $7M | $-2M | $-8M | $-6M | $21M | $-14M | $12M | $-35M | $2M | |
| Free Cash Flow | · | $-2M | · | · | · | $-9M | · | · | · | · | · | · | · | $-25M | · | · |
Rentabilidad 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | · | 68.8% | 73.5% | 78.3% | · | 71.2% | 70.8% | 75.6% | · | 42.1% | · | · | · | · | |
| Operating Margin | -5.4% | -13.7% | · | -10.7% | -4.4% | 8.1% | · | -13.6% | -17.9% | -13.8% | · | -79.3% | -133.5% | -111.6% | · | -157.7% | |
| Net Margin | -14.6% | -23.4% | · | -45.8% | -6.4% | 6.8% | · | -14.8% | -25.6% | -9.1% | · | -79.6% | -132.4% | -110.7% | · | -157.8% | |
| EBITDA Margin | -5.4% | -12.2% | · | -10.7% | -4.4% | 9.5% | · | -13.6% | -17.9% | -11.8% | · | -79.3% | -133.5% | -109.2% | · | -157.7% | |
| ROA | -2.3% | -3.4% | · | -7.4% | -1.1% | 1.2% | · | -2.1% | -4.4% | -1.4% | · | -10.0% | -18.9% | -13.2% | · | -13.4% | |
| ROE | 53.9% | 84.0% | · | 139.3% | 7.3% | -8.5% | · | 14.3% | 23.9% | 14.0% | · | 937.3% | 137.8% | -523.1% | · | -59.3% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.6 | 0.8 | 2.4 | · | 2.3 | 2.4 | 2.5 | · | 2.4 | 1.9 | 2.3 | · | 2.4 | |
| Quick Ratio | 1.2 | 1.2 | · | 1.4 | 0.4 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | 1.0 | 1.0 | · | 1.0 |
Eficiencia 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.3 | · | 0.3 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 |
Valoración (TTM) 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $148M | $149M | · | $147M | $145M | $142M | · | $135M | $134M | $127M | · | $119M | $116M | $107M | · | $101M | |
| Net Income TTM | $-33M | $-25M | · | $-22M | $-14M | $-15M | · | $-42M | $-79M | $-103M | · | $-142M | $-173M | $-195M | · | $-215M | |
| P/E | -2.3 | -5.3 | · | -9.0 | -20.7 | -22.0 | · | -7.1 | -5.8 | -3.4 | · | -0.9 | -0.7 | -0.8 | · | -2.0 | |
| Earnings Yield | -44.2% | -18.8% | · | -11.1% | -4.8% | -4.5% | · | -14.1% | -17.1% | -29.2% | · | -113.6% | -133.6% | -121.2% | · | -49.0% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $155M | $144M | $127M | $108M | $86M |
| Margen Bruto % | 73.3% | 73.2% | 48.8% | — | — |
| Margen Operativo % | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% |
| Beneficio neto | $-20M | $-14M | $-111M | $-182M | $-221M |
| EPS Diluido | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 |
| Ratio Rápido | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-28M | $-24M | $-60M | $-149M | $-206M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 184 declarantes · $51.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 25 (-7 vs trimestre anterior) | 21 (-6 vs trimestre anterior) | 50 (+3 vs trimestre anterior) | 40 (-6 vs trimestre anterior) | -15.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Rubric Capital Management LP | $12 823 986 | 30 046 828 | 24,76% | Acciones |
| Clearline Capital LP | $4 858 675 | 11 383 961 | 9,38% | Acciones |
| Velan Capital Investment Management LP | $3 735 904 | 8 753 290 | 7,21% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 323 230 | 7 782 741 | 6,42% | Acciones |
| Tejara Capital Ltd | $2 778 807 | 6 510 795 | 5,36% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $2 667 500 | 6 250 000 | 5,15% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $1 737 119 | 4 070 101 | 3,35% | Acciones |
| JW Asset Management, LLC | $1 600 958 | 3 751 073 | 3,09% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $1 543 336 | 3 614 773 | 2,98% | Acciones |
| VANGUARD GROUP INC | $1 500 729 | 1 154 407 | 2,90% | Acciones |
| Stonepine Capital Management, LLC | $1 500 000 | 1 000 000 | 2,90% | Opción de compra |
| STATE STREET CORP | $1 377 948 | 3 228 557 | 2,66% | Acciones |
| Pale Fire Capital SE | $1 071 899 | 2 511 478 | 2,07% | Acciones |
| Caption Management, LLC | $896 280 | 2 100 000 | 1,73% | Opción de venta |
| Congress Park Capital LLC | $860 620 | 2 016 447 | 1,66% | Acciones |
| TWO SIGMA ADVISERS, LP | $675 442 | 519 571 | 1,30% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $674 878 | 1 580 510 | 1,30% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $643 145 | 1 506 900 | 1,24% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $582 906 | 1 365 119 | 1,13% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $547 071 | 1 281 796 | 1,06% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $519 613 | 1 217 463 | 1,00% | Acciones |
| Qube Research & Technologies Ltd | $435 802 | 1 021 092 | 0,84% | Acciones |
| Caption Management, LLC | $426 800 | 1 000 000 | 0,82% | Acciones |
| CM Management, LLC | $426 800 | 1 000 000 | 0,82% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $296 270 | 694 165 | 0,57% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $239 958 | 299 910 | 0,46% | Acciones |
| Stonepine Capital Management, LLC | $209 468 | 490 787 | 0,40% | Acciones |
| DIADEMA PARTNERS LP | $195 783 | 458 723 | 0,38% | Acciones |
| Xcelsior Advisor Partners LLC | $173 186 | 405 777 | 0,33% | Acciones |
| Apeiron RIA LLC | $158 163 | 370 579 | 0,31% | Acciones |
| Squarepoint Ops LLC | $137 078 | 321 177 | 0,26% | Acciones |
| Integrated Wealth Concepts LLC | $136 107 | 318 903 | 0,26% | Acciones |
| Glenmede Investment Management, LP | $132 710 | 105 326 | 0,26% | Acciones |
| Richmond Brothers, Inc. | $131 755 | 308 706 | 0,25% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $113 663 | 266 314 | 0,22% | Acciones |
| MARSHALL WACE, LLP | $105 194 | 244 638 | 0,20% | Acciones |
| NEXPOINT ASSET MANAGEMENT, L.P. | $99 359 | 232 800 | 0,19% | Acciones |
| FMR LLC | $96 800 | 226 803 | 0,19% | Acciones |
| Abel Hall, LLC | $90 987 | 213 185 | 0,18% | Acciones |
| CAROLINAS WEALTH CONSULTING LLC | $90 983 | 41 356 | 0,18% | Acciones |
| Horan Securities, Inc. | $86 091 | 41 590 | 0,17% | Acciones |
| RHUMBLINE ADVISERS | $83 482 | 195 537 | 0,16% | Acciones |
| Cutter & CO Brokerage, Inc. | $80 223 | 36 465 | 0,15% | Acciones |
| Quinn Opportunity Partners LLC | $74 837 | 175 344 | 0,14% | Acciones |
| GOLDMAN SACHS GROUP INC | $74 770 | 175 188 | 0,14% | Acciones |
| DLK Investment Management, LLC | $62 615 | 17 890 | 0,12% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58 500 | 137 067 | 0,11% | Acciones |
| Bank of New York Mellon Corp | $54 073 | 126 693 | 0,10% | Acciones |
| D. E. Shaw & Co., Inc. | $51 402 | 120 435 | 0,10% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $51 341 | 120 293 | 0,10% | Acciones |
| Persistent Asset Partners Ltd | $49 974 | 117 090 | 0,10% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 289 | 112 300 | 0,09% | Opción de compra |
| BANK OF AMERICA CORP /DE/ | $46 165 | 108 369 | 0,09% | Acciones |
| Redwood Family Wealth LLC | $45 015 | 105 472 | 0,09% | Acciones |
| Biltmore Family Office, LLC | $42 680 | 100 000 | 0,08% | Acciones |
| DEUTSCHE BANK AG\ | $41 409 | 96 300 | 0,08% | Acciones |
| IEQ CAPITAL, LLC | $41 234 | 96 612 | 0,08% | Acciones |
| BARCLAYS PLC | $37 172 | 87 094 | 0,07% | Acciones |
| SEARLE & CO. | $36 812 | 86 250 | 0,07% | Acciones |
| Vanguard Global Advisers, LLC | $35 764 | 83 756 | 0,07% | Acciones |
| BlackRock, Inc. | $35 761 | 83 788 | 0,07% | Acciones |
| Russell Investments Group, Ltd. | $34 675 | 81 246 | 0,07% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $31 406 | 73 585 | 0,06% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $29 147 | 68 291 | 0,06% | Acciones |
| CITIGROUP INC | $28 050 | 65 721 | 0,05% | Acciones |
| Invesco Ltd. | $27 051 | 63 382 | 0,05% | Acciones |
| LPL Financial LLC | $26 083 | 61 112 | 0,05% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $25 254 | 59 176 | 0,05% | Acciones |
| Anfield Capital Management, LLC | $24 003 | 30 000 | 0,05% | Acciones |
| Mariner, LLC | $23 896 | 55 972 | 0,05% | Acciones |
| NICOLET ADVISORY SERVICES, LLC | $23 840 | 16 000 | 0,05% | Acciones |
| Chicago Partners Investment Group LLC | $23 526 | 51 254 | 0,05% | Acciones |
| CWM, LLC | $23 115 | 28 890 | 0,04% | Acciones |
| Cerity Partners LLC | $22 473 | 52 654 | 0,04% | Acciones |
| CAPTRUST FINANCIAL ADVISORS | $22 000 | 51 547 | 0,04% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $20 003 | 46 868 | 0,04% | Acciones |
| R Squared Ltd | $19 935 | 46 708 | 0,04% | Acciones |
| Centiva Capital, LP | $19 422 | 45 507 | 0,04% | Acciones |
| Nuveen Asset Management, LLC | $19 408 | 12 685 | 0,04% | Acciones |
| INTECH INVESTMENT MANAGEMENT LLC | $17 990 | 42 150 | 0,03% | Acciones |
| HORAN Wealth, LLC | $17 751 | 41 590 | 0,03% | Acciones |
| Prospera Financial Services Inc | $17 308 | 40 565 | 0,03% | Acciones |
| Cornerstone Select Advisors, LLC | $17 057 | 39 964 | 0,03% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $16 647 | 38 987 | 0,03% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $16 369 | 38 352 | 0,03% | Acciones |
| GROUP ONE TRADING LLC | $16 196 | 37 947 | 0,03% | Acciones |
| Creative Planning | $15 306 | 35 862 | 0,03% | Acciones |
| Tower Research Capital LLC (TRC) | $15 180 | 35 567 | 0,03% | Acciones |
| HSBC HOLDINGS PLC | $14 464 | 33 381 | 0,03% | Acciones |
| DDFG, Inc | $14 043 | 32 903 | 0,03% | Acciones |
| Concurrent Investment Advisors, LLC | $13 625 | 31 923 | 0,03% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $13 425 | 32 397 | 0,03% | Acciones |
| CIBC WORLD MARKETS CORP | $13 215 | 10 165 | 0,03% | Acciones |
| Skopos Labs, Inc. | $12 744 | 15 927 | 0,02% | Acciones |
| CoreCap Advisors, LLC | $12 125 | 28 409 | 0,02% | Acciones |
| Vanguard Personalized Indexing Management, LLC | $11 641 | 27 276 | 0,02% | Acciones |
| DIVERSIFIED TRUST CO | $11 306 | 26 492 | 0,02% | Acciones |
| CITADEL ADVISORS LLC | $11 139 | 26 100 | 0,02% | Opción de compra |
| Pallas Capital Advisors LLC | $10 968 | 25 699 | 0,02% | Acciones |
| JANE STREET GROUP, LLC | $10 957 | 25 672 | 0,02% | Acciones |
Informantes de la empresa 39 insiders · 21 directivos · 21 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Craig A Collard | Chief Executive Officer | 31 de julio de 2026 M | 856 492 | 0 | 0 | $0 |
| Barry D Quart | Chief Executive Officer | 18 de enero de 2023 A | 177 989 | 0 | 0 | $0 |
| Ronald J Prentki | President & CEO | 17 de febrero de 2010 A | 40 539 | 0 | 0 | $0 |
| Michael Oconnell | Chief Executive Officer | 10 de enero de 2006 A | 132 200 | 0 | 0 | $0 |
| Ira Duarte | EVP, Chief Financial Officer | 31 de julio de 2026 M | 281 899 | 0 | 0 | $0 |
| Robert Hoffman | CFO & SVP, Finance | 19 de diciembre de 2019 A | 1 280 | 0 | 0 | $0 |
| Brian G. Drazba | VP, Finance & CFO | 31 de octubre de 2016 J | 3 798 | 0 | 0 | $0 |
| John Whelan | CFO | 18 de julio de 2013 M | 254 088 | 0 | 0 | $0 |
| Stephen Whiteford | V.P., Finance & CFO | 15 de diciembre de 2006 A | 15 000 | 0 | 0 | $0 |
| John Poyhonen | President & CCO | 13 de abril de 2023 M | 46 648 | 0 | 0 | $0 |
| Robert Rosen | President | 15 de diciembre de 2018 A | 2 640 | 0 | 0 | $0 |
| David Leslie Szekeres | EVP, Chief Operating Officer | 13 de julio de 2023 M | 33 754 | 0 | 0 | $0 |
| Michael A Adam | Chief Operating Officer | 8 de febrero de 2013 A | — | 0 | 0 | $0 |
| William P Forbes | EVP, Chief Development Officer | 31 de julio de 2026 M | 241 173 | 0 | 0 | $0 |
| Lisa Peraza | VP, Chief Accounting Officer | 19 de enero de 2024 A | 55 907 | 0 | 0 | $0 |
| Kimberly Manhard | EVP, Drug Development | 13 de abril de 2023 M | 28 330 | 0 | 0 | $0 |
| Marshall Paul | SVP, Technical Operations | 21 de marzo de 2016 M | 2 200 | 0 | 0 | $0 |
| Neil James Clendeninn | SVP & Chief Medical Officer | 12 de octubre de 2015 A | — | 0 | 0 | $0 |
| Mark S. Gelder MD | SVP & Chief Medical Officer | 12 de diciembre de 2014 A | — | 0 | 0 | $0 |
| John Barr | Vice President of R&D | 8 de julio de 2011 A | 51 772 | 0 | 0 | $0 |
| Anastassios D. Retzios | VP of Clinical Development | 15 de enero de 2008 A | — | 0 | 0 | $0 |
| Thomas Cusack | Consejero | 30 de enero de 2026 A | 53 960 | 0 | 0 | $0 |
| Morgan Adam | Consejero | 30 de enero de 2026 A | 123 737 | 0 | 0 | $0 |
| Sharmila Dissanaike | Consejero | 30 de enero de 2026 A | 53 960 | 0 | 0 | $0 |
| Michael Kaseta | Consejero | 30 de enero de 2026 A | 53 960 | 0 | 0 | $0 |
| Waage Christian | Consejero | 30 de enero de 2026 A | 53 960 | 0 | 0 | $0 |
| Craig A Johnson | Consejero | 30 de enero de 2026 A | 53 960 | 0 | 0 | $0 |
| Susan Rodriguez | Consejero | 31 de enero de 2025 A | 87 180 | 0 | 0 | $0 |
| Stephen Davis | Consejero | 16 de diciembre de 2022 A | 52 032 | 0 | 0 | $0 |
| KEVIN TANG | Consejero | 19 de diciembre de 2019 A | 5 799 810 | 0 | 0 | $0 |
| Greg Turnbull | Consejero | 29 de mayo de 2012 A | 245 092 | 0 | 0 | $0 |
| Paul Goddard | Consejero | 29 de mayo de 2012 A | 214 683 | 0 | 0 | $0 |
| Toby Rosenblatt | Consejero | 20 de mayo de 2010 A | 210 234 | 0 | 0 | $0 |
| Robert L Zerbe MD | Consejero | 20 de mayo de 2010 A | 202 072 | 0 | 0 | $0 |
| Peter Riepenhausen | Consejero | 28 de mayo de 2008 A | 9 000 | 0 | 0 | $0 |
| Arthur T Taylor | Consejero | 28 de mayo de 2008 A | 12 000 | 0 | 0 | $0 |
| Dennis L Winger | Consejero | 11 de agosto de 2006 A | 69 544 | 0 | 0 | $0 |
| Stephen A Drury | Consejero | 11 de agosto de 2006 J | 83 283 | 0 | 0 | $0 |
| Mark Earl Hensley | — | 6 de agosto de 2026 M | 170 901 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×6 presentaciones | 17 de octubre de 2025 | 15,90% | Enmienda | — | SEC |
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×20 presentaciones | 7 de enero de 2020 | — | Presentación inicial | — | SEC |
| Felix J. Baker, Julian C. Baker ×3 presentaciones | 7 de julio de 2011 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 22 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,28% | 128 515 SH | 8 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,02% | 537 335 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 67 617 NS | 30 de abril de 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 1 328 289 SH | 8 de agosto de 2026 | Diario |
| ITWO · ProShares Trust | 0,00% | 7 231 NS | 31 de mayo de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 198 683 SH | 8 de agosto de 2026 | Diario |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 869 904 NS | 31 de mayo de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 3 609 893 SH | 8 de agosto de 2026 | Diario |
| UWM · ProShares Trust | 0,00% | 5 655 NS | 31 de mayo de 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 505 371 SH | 8 de agosto de 2026 | Diario |
| URTY · ProShares Trust | 0,00% | 5 714 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 144 NS | 31 de mayo de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4 190 NS | 31 de mayo de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 83 361 NS | 31 de mayo de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 28 626 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2 063 361 SH | 8 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5 474 947 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 925 988 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13 208 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 156 616 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12 513 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,00% | 472 185 SH | 8 de agosto de 2026 | Diario |